Kavakli K - Search Results

1

Frequency of acquired von Willebrand's disease in children with congenital heart disease.

Arslan MT, Ozyurek R, Kavakli K, Levent E, Ulger Z, Gurses D, Akyol B, Atay Y. Arslan MT, et al. Among authors: kavakli k. Acta Cardiol. 2007 Aug;62(4):403-8. doi: 10.2143/AC.62.4.2022285. Acta Cardiol. 2007. PMID: 17824302

2

Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease.

Kavakli K, Hüseyinov A, Coker I, Aydinok Y, Nisli G. Kavakli K, et al. Haemophilia. 2001 Sep;7(5):482-9. doi: 10.1046/j.1365-2516.2001.00535.x. Haemophilia. 2001. PMID: 11554936

3

Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid.

Serdaroglu G, Tütüncüoglu S, Kavakli K, Tekgül H. Serdaroglu G, et al. Among authors: kavakli k. J Child Neurol. 2002 Jan;17(1):41-3. doi: 10.1177/088307380201700110. J Child Neurol. 2002. PMID: 11913569

4

Resemblance to vWD types and laboratory diagnosis of obligatory carriers of type 3 von Willebrand disease.

Akin M, Karapinar DY, Balkan C, Ay Y, Kavakli K. Akin M, et al. Among authors: kavakli k. Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E21-4. doi: 10.1177/1076029610379847. Epub 2010 Aug 16. Clin Appl Thromb Hemost. 2011. PMID: 20713487 Free article.

5

Investigation of acquired von Willebrand Syndrome in children with hypothyroidism: reversal after treatment with thyroxine.

Olukman O, Sahin U, Kavakli T, Kavakli K. Olukman O, et al. Among authors: kavakli t, kavakli k. J Pediatr Endocrinol Metab. 2010 Sep;23(9):967-74. J Pediatr Endocrinol Metab. 2010. PMID: 21175099

6

The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms.

Akin M, Balkan C, Karapinar DY, Kavakli K. Akin M, et al. Among authors: kavakli k. Clin Appl Thromb Hemost. 2012 Jun;18(3):316-9. doi: 10.1177/1076029611422364. Epub 2011 Sep 23. Clin Appl Thromb Hemost. 2012. PMID: 21949039 Free article. Clinical Trial.

7

Laboratory diagnosis and management of von Willebrand disease in Turkey: Izmir experience.

Akin M, Kavakli K. Akin M, et al. Among authors: kavakli k. Semin Thromb Hemost. 2011 Jul;37(5):581-6. doi: 10.1055/s-0031-1281046. Epub 2011 Nov 18. Semin Thromb Hemost. 2011. PMID: 22102203 Review.

8

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery.

Peyvandi F, Mamaev A, Wang JD, Stasyshyn O, Timofeeva M, Curry N, Cid AR, Yee TT, Kavakli K, Castaman G, Sytkowski A. Peyvandi F, et al. Among authors: kavakli k. J Thromb Haemost. 2019 Jan;17(1):52-62. doi: 10.1111/jth.14313. Epub 2018 Dec 20. J Thromb Haemost. 2019. PMID: 30362288 Free PMC article. Clinical Trial.

9

Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children.

Kavakli K, Canciani MT, Mannucci PM. Kavakli K, et al. Pediatr Hematol Oncol. 2002 Oct-Nov;19(7):467-73. doi: 10.1080/08880010290097288. Pediatr Hematol Oncol. 2002. PMID: 12217192

10

The elevated markers of hypercoagulability in children with Henoch-Schönlein purpura.

Yilmaz D, Kavakli K, Ozkayin N. Yilmaz D, et al. Among authors: kavakli k. Pediatr Hematol Oncol. 2005 Jan-Feb;22(1):41-8. doi: 10.1080/08880010590896251. Pediatr Hematol Oncol. 2005. PMID: 15770830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters